BIRAC–RDI Fund – Research, Development and Innovation Fund

Delta Change Challenge for Biotech Innovation – Biotechnology Industry Research Assistance Council (BIRAC), under Department of Biotechnology (DBT)

Delhi

Agritech, AI / ML, Bio Tech, Climate Technology, Healthcare

0 (0 Reviews)

New

₹2,000,000,000.00

An infographic poster for the BIRAC-RDI Fund depicting a glowing technological path transitioning from microscopic DNA and microchips to an industrial bioreactor, ending at a futuristic city skyline. Text highlights a ₹2,000 Crore financing window, offering ₹5 Cr to ₹200 Cr for deep-tech innovation and indigenous manufacturing.

Add StartupMandi as Preferred Source on

Add Us as Preferred Source on

Application Start Date

February 14, 2026

Deadline to Submission

March 31, 2026

Shortlist / Result Announcement Expected Date

April 6, 2026

Eligibilie Stages

MVP Stage, Early Revenue Stage, Growth Stage

N.B.

Focus heavily on "Delta-Change": The evaluating committee is looking for transformative, global benchmark-setting innovations, not incremental or minor improvements.

Co-funding is mandatory: Have a clear, documented strategy for how you will secure the remaining 50% of the project capital, as disbursements are linked to co-funding commitments.

Highlight National Impact: Explicitly emphasize how your product reduces import dependency and contributes to India's indigenous supply-chain resilience.

Grant Application Direct URL

https://app.biracrdif.org/ext/form/20359/1/apply

Most Recent Grants

Blockchain India Challenge – Get Up to ₹50 Lakh

Apply Now

BIRAC–RDI Fund – Research, Development and Innovation Fund

Apply Now

Let StartupMandi apply for this Grant on your behalf

Share your basic details and the StartupMandi Professional Team will review your eligibility and guide you through the application process

Accelerate Your Deep-Tech Innovation with the BIRAC-RDI Fund

The BIRAC–RDI Fund is a transformative ₹2,000 Crore financing window under the Government of India’s ₹1 Lakh Crore RDI initiative. Designed to catalyze high-impact deep-tech innovation, this fund provides a massive boost to indigenous manufacturing in biotechnology and related sectors.

What This Grant Offers

This initiative offers patient capital and risk-mitigating support through a co-investment model.

Funding Size: Ranging from ₹5 Crore up to ₹200 Crore.
Co-Investment: Funding support extends up to 50% of the assessed project cost to crowd in private capital and reduce technological risk.
Funding Instruments: Delivered through equity, convertible instruments, and long-term debt.

Purpose and Strategic Impact

Anchored in the vision of Viksit Bharat 2047, the BIRAC-RDI Fund focuses on enabling “delta-change” innovations rather than incremental improvements. It prioritizes:

Reprogramming Biology: AI-engineered designer enzymes and extreme-condition stable proteins.
Foundational Bio-Platforms: Architectures enabling multiple IP families and global standard-setting.
Supply-Chain Resilience: Advanced manufacturing that breaks the import dependency trap (e.g., reagents, viral vectors, complex media).

Key Benefits for Applicants:

Unprecedented Capital Access: Bridges the critical gap between laboratory research and commercial-scale manufacturing.
Long-Term Growth Partner: Built to support long-gestation, high-risk research requiring patient capital.
National Recognition: Establishes your entity as a key driver of India’s $300 billion bioeconomy target by 2030.

If your deep-tech project is ready for scale-up, clinical validation, or industrial manufacturing, the BIRAC-RDI Fund is your ultimate growth catalyst.

Eligibility

Registration Requirement: Must be a legally registered and incorporated entity in India (Companies Act 2013, LLP Act 2008, etc.), including DPIIT-recognized startups.

Geographic Operations: Must have the principal place of business/operations in India and a registered global headquarters in India.

Ownership & Control: The entity must be ultimately owned and under the control of resident Indian citizens as defined in the DPIIT Consolidated FDI Policy.

Technology Readiness: Projects must be at Technology Readiness Level (TRL) 4 and above (validated proof-of-concept ready for scale-up).

Sector Focus: Engaged in ROI-intensive technologies in biopharma, bio-industrial manufacturing, bioenergy, AI-ML in biotech, or climate solutions aligned with national priorities.

Financial Requirement: Financing under this fund shall not exceed 50% of the total assessed project cost. The applicant must arrange the remaining ≥50% from their own or commercial resources.

Location Eligibility

All Indian startups/companies (Eligible Technology Entities in India).

Don't Miss the Offers